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Aims Coronary late stent thrombosis, a rare but devastating complication, remains an important concern in particular with
the increasing use of drug-eluting stents. Notably, pathological studies have indicated that the proportion of uncov-
ered coronary stent struts represents the best morphometric predictor of late stent thrombosis. Intracoronary
optical frequency domain imaging (OFDI), a novel second-generation optical coherence tomography (OCT)-
derived imaging method, may allow rapid imaging for the detection of coronary stent strut coverage with a markedly
higher precision when compared with intravascular ultrasound, due to a microscopic resolution (axial 10–20 mm),
and at a substantially increased speed of image acquisition when compared with first-generation time-domain OCT.
However, a histological validation of coronary OFDI for the evaluation of stent strut coverage in vivo is urgently
needed. Hence, the present study was designed to evaluate the capacity of coronary OFDI by electron (SEM) and
light microscopy (LM) analysis to detect and evaluate stent strut coverage in a porcine model.
Methods
and results
Twenty stents were implanted into 10 pigs and coronary OFDI was performed after 1, 3, 10, 14, and 28 days. Neoin-
timal thickness as detected by OFDI correlated closely with neointimal thickness as measured by LM (r ¼ 0.90,
P, 0.01). The comparison of stent strut coverage as detected by OFDI and SEM analysis revealed an excellent agree-
ment (r ¼ 0.96, P, 0.01). In particular, stents completely covered by OFDI analysis were also completely covered by
SEM analysis. All incompletely covered stents by OFDI were also incompletely covered by SEM. Analyses of fibrin-
covered stent struts suggested that these may rarely be detected as uncovered stent struts by OFDI. Importantly,
optical density measurements revealed a significant difference between fibrin- and neointima-covered coronary
stent struts [0.395 (0.35–0.43) vs. 0.53 (0.47–0.57); P, 0.001], suggesting that differences in optical density
provide information on the type of stent strut coverage. The sensitivity and specificity for detection of fibrin vs.
neointimal coverage was evaluated using receiver-operating characteristic analysis.
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Conclusion The present study demonstrates that OFDI is a highly promising tool for accurate evaluation of coronary stent strut
coverage, as supported by a high agreement between OFDI and light and electron microscopic analysis. Furthermore,
our data indicate that optical density measurements can provide additional information with respect to the type of
stent strut coverage, i.e. fibrin vs. neointimal coverage. Therefore, coronary OFDI analysis will provide important
information on the biocompatibility of coronary stents.
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Introduction
Since their introduction in 2001, drug-eluting stents (DES) have
markedly changed the treatment of coronary artery disease due
to a substantial reduction of repeat revascularization procedures
compared with bare metal stents (BMS).1 However, with the
increasing clinical use of DES, evaluation of the safety of these
devices has become an important issue. In particular, DES have
been associated with an increased risk of late stent thrombosis
and its potentially devastating consequences such as myocardial
infarction and death.2 –6 Recent pathological studies have suggested
that the number of uncovered stent struts was associated with a
markedly increased risk for late stent thrombosis.7– 10 Further-
more, the ratio of uncovered to total stent struts was identified
as the morphometric parameter that best correlated with the
degree of stent endothelialization.7
While in patients with coronary disease, stent strut coverage
cannot be reliably identified by intracoronary intravascular ultra-
sound (IVUS) analysis, optical coherence tomography (OCT), a
novel imaging tool with a substantially higher axial image resolution
of about 10–20 mm has been developed as an important advance-
ment for in vivo evaluation of coronary stents.11 In a 2-year
follow-up observation by coronary OCT in patients that had
received a first-generation sirolimus-eluting stent, a substantial
portion of patients had remaining cross-sections with more than
30% uncovered stent struts.12 Moreover, OCT evaluation of cor-
onary DES implanted in patients with ST-elevation myocardial
infarction revealed a higher frequency of uncovered stent struts
at follow-up when compared with patients with stable coronary
disease.13 These observations are in line with recent pathological
observations suggesting that the ratio of uncovered to total stent
struts is increased in patients with an acute coronary syndrome
after DES implantation.14 Moreover, acute coronary syndromes
have been identified as predictors of late stent thrombosis after
DES implantation.5
After the introduction of first-generation time-domain OCT
imaging systems for clinical studies, which frequently required cor-
onary occlusion for reliable high-quality image acquisition, the
second generation of OCT imaging systems, i.e. optical frequency
domain imaging (OFDI), has provided a substantial advance due
to a markedly increased speed of image acquisition.15 Yun et al.
have described the development of the prototype of this technol-
ogy, i.e. the fibre-optic imaging device for OFDI.16 These authors
have reported a three-dimensional resolution of approximately
15 × 15 × 10 mm by using the first OFDI-prototype system.
Optical frequency domain imaging substantially improves the
feasibility of this intracoronary imaging method and reduces
patient discomfort during image acquisition; however, the charac-
terization of stent strut coverage by this method remains to be
evaluated against light and electron microscopic analysis of stent
strut coverage. The present study was therefore designed to vali-
date in an in vivo model the analysis of stent strut coverage using
these methods. Furthermore, we examined differences in optical
density of stent strut coverage at different time points after stent
implantation in order to determine whether there is a difference
with respect to optical density between fibrin- and neointima-
covered stent struts.
Methods
Animal study protocol
Twenty stents (3.0 × 18 mm) were implanted in a total of 10 farm
swine (Landrace Large White Duroc pigs, aged 8–10 weeks) into
the left anterior descending and the ramus circumflexus. Animals
were medicated with acetylsalicylic acid (ASS, 500 mg daily p.o.) and
ticlopidine (200 mg daily p.o.) for 3 days before stent implantation.
Immediately before implantation, 200 IU/kg unfractionated heparin
was administered via the introducer. Suitable implantation sites
within the vessels were identified by angiography (target vessel diam-
eter between 2.5 and 2.75 mm) and stents (10 BMS; Terumo CoCr,
and 10 DES; Biolimus A9 eluting Terumo Nobori) were implanted
with a vessel overstretch of 10–20%. After operation, the animals
were allowed to recover while under continuous medication of ASS
(500 mg daily p.o.) and ticlopidine (200 mg daily p.o.) for the duration
of the study. Optical frequency domain imaging was performed after
stent implantation and at follow-up after 1, 3, 10, 14, and 28 days
(four stents each time point). Immediately after follow-up angiography
animals were sacrificed by exsanguinations under deep anaesthesia.
Hearts were explanted; coronary arteries were perfused with saline
solution and 4% formalin for 10 min. The present investigation con-
forms to the Guide for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (NIH Publication 85-23,
revised 1996). The study protocol has been approved by the local
veterinary inspection office. Study procedures, including pathologic
evaluation, were performed in compliance with good laboratory
practices.
Optical frequency domain imaging image
acquisition and analysis
The Terumo-OFDI catheter was advanced over a 0.014-inch guide
wire and the imaging core was placed distal of the stent. The catheter
position was confirmed by the radiopaque markers of the OFDI cath-
eter. This OFDI system provides images at 160 frames/s with a total
of 512 radial scans per circular cross-sectional image.17 The
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Terumo-OFDI system has an axial resolution of ,20 mm and a lateral
resolution of 30 mm (at 2.5 mm) according to the manufacturer’s infor-
mation (New Technology Development Group, Terumo R&D
Center). The acquisition of OFDI images was performed using the
automatic pull-back at a speed of 20 mm/s17 after manual injection
of contrast (Ultravist-300, Bayer Schering Pharma) at a rate of
2–4 mL/s (based on the runoff of the artery) for approximately
4–6 s under continuous online assessment of OFDI image quality
(in particular demonstrating that the blood was completely displaced
from the artery during the whole image acquisition time).
Optical frequency domain imaging images were analysed offline in
each cross section by two independent investigators (C.T. and M.M.)
blinded to the histological examination and all stent struts were classi-
fied as either uncovered or covered stent struts. Stent struts were
classified as uncovered if any part of the strut was visibly exposed to
the lumen and covered if tissue was visible over all of the circumfer-
ence of the strut. Metallic stent struts typically appear as bright,
signal intense structures with dorsal shadowing.
Electron microscopy analysis
For scanning electron microscopy (SEM), tissue fixation was per-
formed as described previously.18 Briefly, the samples were transferred
from Formalin 4% to a solution of 2.5% glutaraldehyde in 0.1 M caco-
dylate buffer (pH 7.4, 350 mOsm) for 3 days. The vessels were opened
by a longitudinal cut, the two parts of the vessel were washed, dehy-
drated in ascending concentrations of ethanol, and finally critical point
dried. Critical point drying was used as a tissue preparation method for
SEM as commonly applied for this technique.19,20
Samples were then mounted on aluminium stabs, sputter-coated
with gold, and viewed under a Philips XL 30 FEG scanning electron
microscope at different magnifications. The extent of surface coverage
above stent struts was traced and measured by iTEM morphometry
software (iTEM Analyses imaging program; Olympus Soft Imaging Sol-
utions, 48149 Mu¨nster, Germany). The results are expressed as a per-
centage of total surface area above struts. Endothelial cells were
identified as sheets of spindle- or polygonal-shaped monolayers in
close apposition. In contrast, fibrin coverage was characterized by
fibrin aggregates intermixed with red blood cells and inflammatory
cells. The percentage of stent strut coverage was determined using
computer-assisted planitometry and type of coverage (endothelium/
neointima vs. fibrin) was assessed by two experienced pathologists
blinded to the stent type. Percent coverage was compared with the
corresponding OFDI images. Struts over side-branches were excluded
for both the analyses. To determine whether optical density of OFDI
images was related to the type of stent strut coverage (fibrin vs. neoin-
tima), the optical density was measured as described below.
The comparison of stent strut coverage between OFDI and SEM
was performed for 13 stents, where the preparation was possible
without clear artefacts destroying stent coverage. Seven stents had
substantial loss of coverage clearly attributable to preparation arte-
facts, and could therefore not be included into the analysis.
Light microscopy analysis
Stents were embedded for light microscopy (LM) analysis in poly-
methyl methacrylate21 and stained with haematoxylin/eosin as well
as Elastica van Gieson. An image analysis system was used for histo-
morphometric measurements (Olympus Vanox-S). The system was
calibrated prior to each measurement session against a standard.
Images were captured with a CCD video camera (JVC, KY55) and
neointimal thickness was measured with Analysis v.3.0 (Soft Imaging
Systems, 48149 Mu¨nster, Germany). The correspondence of LM and
OFDI images was confirmed using landmarks, such as stent edges
and side-branches as described previously (Figure 1).22 Neointimal
thickness as determined by OFDI and LM was statistically compared
as described below.
Optical density analysis of stent strut
coverage
Pixel intensity (optical density) of stent strut coverage in OFDI
images, normalized for optical density of the stent struts, was evalu-
ated as a potential predictor of the type of stent strut coverage. In
particular, optical density was determined for stent struts covered
by fibrin vs. neointima. Computer-assisted densitometric analysis
was performed as described previously23 to compare the optical
intensity of areas of stent struts (is) with the intensity of the sur-
rounding tissue facing the intraluminal side of the strut (it, Figure 2)
by using Genetools software (Syngene, Cambridge, UK). The quoti-
ent (it/is) was correlated to the morphologic information gathered
by the SEM and LM evaluation for stents which were covered with
fibrin (Days 1 and 3; 56 SEM and LM spots) and for stents which
were covered by neointima (Days 10, 14, and 28; 104 SEM and
LM spots). These stents served as references to establish ranges of
(it/is) for fibrin and neointimal coverage. Then we evaluated struts
in 160 randomly chosen images at the different time points after
stent implantation (32 images/time point), calculated the (it/is)-
quotient and showed the changes of optical density of stent strut
coverage as assessed by OFDI over time.
Statistics
The rate of covered stent struts in OFDI images was calculated in
relation to total stent struts counted in the segments corresponding
to electron microscopy (SEM) images. Data are reported as means
and standard error for normally distributed continuous data or
medians with interquartile ranges for non-normally distributed data.
The association between OFDI and SEM analysis was calculated
using Pearson’s correlation coefficient. Student’s t-test (two-sided)
was used for the statistical comparison of normally distributed con-
tinuous data, Mann–Whitney U-test (two-sided) was used for the
statistical comparison of non-normally distributed continuous data.
Receiver-operating characteristics (ROC) analysis was used to
compare diagnostic accuracy of optical density analysis of OFDI
images of stent strut coverage for detecting fibrin- vs. neointima-
covered stent struts. Area under the ROC curve (AUC) was calcu-
lated to compare the accuracy of the approach. The agreement
between neointimal thickness as measured by OFDI and LM analysis
was examined by Bland–Altman plots.24 Statistical analyses were per-
formed using SPSS for Windows software (release 18.0; SPSS Inc.,
Chicago, IL, USA). P-values ,0.05 were considered statistically
significant.
Results
The OFDI imaging procedure was successfully performed in
all animals and a good visualization of the coronary artery wall
was obtained. A total number of 7929 stent struts were evaluated
in the OFDI analysis. Stent strut apposition was observed in all
cases.
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Relation of coronary stent strut coverage
as detected by in vivo optical frequency
domain imaging and scanning electron
microscopy analysis
The OFDI measurements of stent strut coverage were highly
reproducible, i.e. the interobserver correlation was r ¼ 0.98
(P, 0.01). Notably, the comparison of stent strut coverage as
detected by OFDI and SEM analysis revealed an excellent
agreement (r ¼ 0.96, P, 0.01, Table 1, Figure 1).
In particular, stents that were completely covered according to
OFDI analyses were also completely covered in the SEM analysis.
Stents that had uncovered struts by OFDI analysis had also uncov-
ered struts by the SEM analysis. The mean value of stent strut cov-
erage of fibrin-covered stents, examined early after stent
implantation, tended to be lower when stent strut coverage was
determined by OFDI when compared with the SEM analysis,
although this did not reach statistical significance (Table 1).
However, we cannot exclude that fibrin-covered stent struts
may rarely appear as uncovered by OFDI (Table 1). Notably, this
was not observed for neointima-covered stents (Table 1). The
minimal differences in the percentages of uncovered stent struts
between OFDI and SEM at later time points may likely relate to
the different measurement approaches (OFDI analyses from sec-
tions vs. SEM analyses by planimetry).
Evaluation of the optical density of stent
strut coverage to distinguish between
fibrin and neointimal stent strut coverage
For the analysis of the optical density of stent strut coverage com-
pletely fibrin-covered stents (1–3 days after implantation) and
stents completely covered by a neointima (10–28 days after
implantation) according to the light and electron microscopic
analysis were used. These densitometric measurements of the
different types of stent strut coverages (i.e. fibrin- vs. neointima-
covered stent struts) revealed significant differences in the
optical intensity (normalized for the optical density of the stent
struts; it/is). The median of normalized optical density of stent
strut coverage was significantly lower for fibrin-covered when
compared with neointima-covered stent struts [0.395 interquartile
range (0.35–0.43) vs. 0.53 interquartile range (0.47–0.57);
P, 0.001; n ¼ 56–104; Figures 2 and 3A].
The diagnostic accuracy of the optical density measurements
was assessed by ROC curve analysis for differentiating fibrin vs.
neointimal stent strut coverage. The ROC curve analysis revealed
an excellent diagnostic accuracy of the optical density measure-
ments (AUC ¼ 0.859, Figure 3B). When an optical density of
0.44 (it/is) was considered as a cut-off value, the sensitivity
of detecting neointimal coverage was 82.7% with a specificity of
83.9%. Fibrin coverage was detected at the same cut-off value
Figure 1 Representative corresponding images of scanning electron microscopy (SEM) and optical frequency domain imaging (OFDI) analysis
of the same stent segment. (A) Overview in SEM; (B) details of the side-branch in SEM; (C ) overview in OFDI; (D–G) sequential OFDI images
showing covered and uncovered stent struts corresponding to the marked positions in the electron microscopy image in (B); (F) shows one
strut covered (upper) and one strut blank (lower) as seen on the SEM image as well.
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with a sensitivity of 83.9% and a specificity of 82.7%. For values of
optical density .0.53 (it/is), neointimal coverage was detected
with a specificity of .95% (‘safe area’), whereas values of
optical density ,0.38 (it/is) specify fibrin-covered stent struts
with a specificity .95%. Figure 3C shows the values of the nor-
malized optical density of tissue covering stent struts at different
time points. The time course shows the development of optical
density of stent strut covering tissue from Days 1 to 28, i.e.
associated with the change from fibrin to neointimal coverage
of stent struts. Therefore, densitometric analysis may represent
a promising tool to get further information on the type of
stent strut coverage.
Figure 2 Different characteristics of stent strut coverage at different time points after stent implantation, i.e. fibrin- vs. neointima-covered
stent struts. (A) Fibrin at Day 3 in scanning electron microscopy (SEM) and optical frequency domain imaging (OFDI), where a low intensity
of stent strut coverage can be seen (A′′′ ′); (B) neointima at Day 10 in SEM and OFDI, where stent strut coverage with higher intensity
when compared with fibrin can be observed; (C) neointima at Day 28 in SEM and OFDI, where a high intensity of stent strut coverage is
present (is, intensity of strut; it, intensity of tissue).
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Relation of neointimal thickness as
detected by optical frequency domain
imaging and light microscopic analysis
There was an excellent agreement between coronary OFDI
and light microscopic analysis of neointimal thickness (r ¼ 0.90,
P, 0.01). The Bland–Altman analysis is shown in Figure 4, demon-
strating the agreement between neointimal thickness measurements
obtained by LM and OFDI analysis. 89.9% of struts detected by LM
were visible in OFDI (Figure 5). The remaining struts were not
detectable due to the small segment of the coronary wall that was
covered by the guide wire (i.e. guide wire artefact). Measurements
of very early time points (i.e. Days 1 and 3) were not included due
to the limited presence of neointimal coverage.
Discussion
With the increasing use of DES, the evaluation of the safety and
biocompatibility of these devices in patients has become an impor-
tant concern. Pathological studies have suggested that the pro-
portion of uncovered coronary stent struts represents the best
morphometric predictor for late DES thrombosis. Recently, coron-
ary OFDI has emerged as a novel, highly rapid coronary imaging
method for the assessment of coronary stent strut coverage in
patients in vivo; however, the accuracy of this imaging method
needs to be further evaluated. The present study demonstrates a
high agreement between coronary OFDI and light and electron
microscopic analysis for the evaluation of coronary stent strut cov-
erage in an in vivo model. Moreover, our data indicate that optical
density measurements provide additional information with respect
to the type of stent strut coverage, i.e. fibrin vs. neointimal cover-
age that may further aid in the assessment of the in vivo biocompat-
ibility of coronary stents. In addition, neointimal thickness as
detected by OFDI correlated closely with neointimal thickness as
measured by LM, suggesting an excellent agreement between
these quantitative measures.
Late coronary DES thrombosis, although a rare complication,
remains an important concern owing to its high morbidity and
mortality and the increasing use of DES,2– 6 due to the reduced
necessity of repeated coronary revascularization procedures
when compared with BMS.1 Of note in this regard, Finn et al.7
have observed in pathological studies that the percentage of
uncovered stent struts represented the best morphometric predic-
tor of late DES thrombosis. In particular, these authors observed a
continuum of risk for LST for individuals that increases with the
percentage of uncovered stent struts per section, i.e. in a stent
with 30% uncovered struts, the odds ratio for thrombosis is 9.0
when compared with a stent with complete stent strut coverage.7
Therefore, there is a great interest in an adequate in vivo evaluation
of coronary stent strut coverage.
Notably, OCT has emerged as a promising in vivo coronary
imaging technology utilizing infrared light to achieve a substantially
higher resolution of cross-sectional images when compared with
coronary IVUS.11 Indeed, first-generation OCT has a markedly
increased capacity to detect coronary stent strut coverage when
compared with coronary IVUS analysis.11 However, first-
generation OCT systems are limited by a rather low image acqui-
sition speed. The second-generation OCT imaging system has the
advantage of a substantially accelerated coronary image acquisition,
thus avoiding the need of the proximal occlusion of the coronary
artery for high-quality image acquisition. These developments have
markedly improved the feasibility of this novel coronary imaging
method. However, an evaluation with respect to the accuracy
for detection of stent strut coverage in vivo when compared with
light and electron microscopic analysis is urgently needed.
The detection of the presence or absence of neointimal cover-
age may potentially be limited by the resolution of OFDI. Thus,
struts classified as uncovered by OFDI might still have a very
thin coverage of tissue of less than 10–20 mm. Although the bio-
logical protection offered by such a thin coverage is debatable,
struts might in fact be covered by an endothelial layer of less
than 10–20 mm thickness. However, the histological evaluation
performed in the present in vivo study suggests that neointimal cov-
erage of stents as assessed by OFDI compares very well with this
gold standard. In particular, the stent strut coverage as detected by
OFDI analysis was not lower when compared with the data
obtained by the histological analysis. Only in fibrin-covered
stents, very early after stent implantation, it appeared that these
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Table 1 Comparison of stent strut coverage by optical
frequency domain imaging and scanning electron
microscopy analysis
Coverage OFDI
(coverage in %)
SEM
(coverage in %)
Completely
neointima-covered stents
100 100
100 100
Mean value 100 100
Incompletely
neointima-covered stents
97 96
99 98
99 96
99 95
99 98
98 99
Mean value+ SEM 98.5+0.1 97+0.3
Fibrin covered stents 76 69
70 72
53 58
49 65
Mean value+ SEM 62+3.3 66+1.5
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may rarely be falsely classified as uncovered struts by OFDI, when
fibrin coverage was detected by the SEM analysis. However, fibrin
coverage of stent struts has also been observed in conditions
associated with an increased risk of stent thrombosis.8,14,25
Indeed, the distinction of fibrin vs. endothelial coverage might be
important for proper assessment of novel stents in patients. We
therefore examined whether the determination of the optical
density of stent strut coverage may aid in distinguishing between
fibrin and neointimal coverage of stent struts, as validated in an in
vivo model by electron and light microscopic analysis that has not
been possible until now.25 Of interest, impaired stent healing with
a persistent fibrin deposition has been observed late after coronary
implantation of DES,8 likely as a consequence of an incomplete
endothelial repair process. In this respect, we and others have
recently observed that sirolimus and similar compounds do not
only inhibit vascular smooth muscle cell proliferation, but also endo-
thelial cell growth.26 Interestingly, the percentage of fibrin-covered
stent struts is increased in patients with DES implantation and
ACS and in those receiving overlapping DES.8,14,25 Importantly,
both conditions have been associated with an increased risk of
late stent thrombosis.8,14,25 In the present analysis, fibrin-covered
stent struts had a lower optical density when compared with stent
struts covered by a neointima. Safe areas as well as an appropriate
cut-off value for distinction of fibrin vs. neointimal stent strut cover-
age were obtained using histologically validated densitometric
measurements. These observations raise the possibility that OFDI
may not only allow adequate detection of stent strut coverage in
vivo, but may also aid in the characterization of the type of stent
Figure 3 Assessment of the optical density of the optical frequency domain imaging (OFDI) images of stent strut coverage—differences
between fibrin vs. neointimal stent strut coverage. (A) Densitometric analysis of OFDI images with histologically approved fibrin- and neointima-
covered stent struts (medians with interquartile ranges); (B) receiver-operating characteristic curve of data presented in (A); (C) densitometric
analysis of the development of neointimal coverage of stents at different time points after stent implantation.
Figure 4 Relation of measurements of neointimal thickness between light microscopic (LM) and optical frequency domain imaging (OFDI)
analysis on Days 10–28 after coronary stent implantation. Dot plot (A) and log transformation of Bland–Altman plot (B; red lines ¼ limit of
agreements) are shown demonstrating the agreement between neointimal thickness measurements obtained by light microscopy and OFDI
analysis.
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strut coverage. Therefore, OFDI analysis provides valuable infor-
mation on the coronary stent strut coverage not available with pre-
vious imaging systems that will aid in the assessment of the
biocompatibility of coronary stent systems in vivo.
Limitations of the study
The comparison of OFDI and light and electron microscopic analysis
of coronary stent strut coverage was performed after stent
Figure 5 Corresponding images of light microscopic (LM) and optical frequency domain imaging (OFDI) analysis of neointima measurements.
The image wire and the guide wire shadow have been marked in OFDI (white) and on their corresponding sites in LM (black), matching pairs
were found as positions of LM images in the stent were known and positions of OFDI images could be calculated from the number of images
between start and end of the stent. (A) Day 3, one strut on OFDI is hidden behind the guide wire shadow, one is hidden behind the image wire
shadow (indicated by asterisks); (B) Day 14, again, one strut is hidden behind the guide wire shadow in the OFDI image (asterisks); (C) Day 28
LM vs. OFDI, all struts are visible in OFDI and LM images, measurement of neointimal thickness is marked in red.
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implantation into porcine coronary arteries without coronary
disease, whereas in the clinical setting stent implantation is per-
formed into coronary arteries with coronary disease, and this
should be acknowledged as a potential limitation of the present
study. However, coronary arteries in domestic crossbred swine
are suitable as their size, access, and injury response are similar to
human vessels, and have therefore been considered a particularly
valuable model in pre-clinical evaluation of stent healing.27
Conclusions
Based on pathological studies, the proportion of uncovered coron-
ary stent struts has been identified as a potent risk factor for late
stent thrombosis of DES. The present study evaluated the accuracy
of coronary OFDI for the detection of uncovered stent struts by
comparing OFDI with light and electron microscopic analysis in a
porcine coronary artery model, and demonstrates a close relation
between stent strut coverage as assessed by OFDI and micro-
scopic analysis. Furthermore, our study suggests that the optical
density of OFDI-detected stent strut coverage is different for
fibrin- vs. neointima-covered stent struts. Therefore, coronary
OFDI represents a highly promising technology for the character-
ization of stent strut coverage and a valuable tool for the assess-
ment of coronary stent biocompatibility.
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